gram-positive

(redirected from Gram-positive bacterial infections)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to Gram-positive bacterial infections: Pathogenic bacteria

gram-positive

 [gram-poz´ĭ-tiv]
retaining the stain or resisting decolorization by alcohol in Gram's method of staining; see Gram stain. This is a primary characteristic of bacteria whose cell wall is composed of peptidoglycan and teichoic acids.

gram-pos·i·tive

(gram-pos'i-tiv), In this expression gram begins with lowercase g but: Gram stain.
Refers to the ability of a type of bacterium to resist decolorization with alcohol after being treated with crystal violet stain, which imparts a violet color to the bacteria when viewed by light microscopy. This reaction is usually an indication that the outer structure of the bacterium consists of a cytoplasmic membrane surrounded by a thick rigid bacterial cell wall composed of peptidoglycan. See: Gram stain.

gram-positive

/gram-pos·i·tive/ (-poz´it-iv) retaining the stain or resisting decolorization by alcohol in Gram's method of staining, a primary characteristic of bacteria whose cell wall is composed of peptidoglycan and teichoic acid.

gram-positive

or

Gram-positive

(grăm′pŏz′ĭ-tĭv)
adj.
Of, relating to, or being a bacterium that retains the violet stain used in the Gram stain method.

gram-positive

Etymology: Hans C.J. Gram; L, positivus
retaining the violet color of the stain used in Gram's method of staining microorganisms. This property is a primary method of characterizing organisms in microbiology. Some of the most common kinds of gram-positive pathogenic bacteria are Bacillus anthracis, Clostridium species, Mycobacterium leprae, Mycobacterium tuberculosis, Staphylococcus aureus, Streptococcus pneumoniae, and Streptococcus pyogenes.

gram-pos·i·tive

(gram-poz'i-tiv)
Refers to the ability of a bacterium to resist decolorization with alcohol after being treated with Gram crystal violet stain, imparting a violet color to the bacterium when viewed by light microscopy.
See: Gram stain

Gram-positive

see GRAM'S STAIN.

Gram-positive

Referring to a bacteria that takes on a purplish-black color when exposed to Gram's stain.
Mentioned in: Aminoglycosides

gram-pos·i·tive

(gram-poz'i-tiv)
Refers to the ability of a type of bacterium to resist decolorization with alcohol after being treated with crystal violet stain, which imparts a violet color to the bacteria when viewed by light microscopy.

gram-positive,

n retaining the violet color of the stain used in Gram's method of staining microorganisms. Staining property is a common method of classifying bacteria. See also Gram's stain.

gram-positive

said of bacteria that resist decolorization by alcohol in Gram's method of staining (see gram's stain) and thus retain the crystal violet-iodine complex and appear purple; a characteristic of bacteria whose cell wall is composed of a thick layer of peptidoglycan and teichoic acid.
References in periodicals archive ?
A review of the Gram-Positive Bacterial Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Nabi Biopharmaceuticals is focused on developing products that address unmet medical needs and offer commercial opportunities in our core business areas: hepatitis and transplant, kidney disease (nephrology) gram-positive bacterial infections and nicotine addiction.
By facilitating the benchmarking of regional data against national trends, the registry is intended to improve information flow on the standards of care for patients treated for serious Gram-positive bacterial infections.
Cidecin is Cubist Pharmaceuticals' product currently in late-stage development for the treatment of gram-positive bacterial infections.
Oritavancin is a semi-synthetic glycopeptide antibiotic in development for the treatment of a broad range of resistant gram-positive bacterial infections.
The collaboration, which began in 1997, is focused on the identification and development of a new class of anti-infective agents targeting Gram-positive bacterial infections.
25, Microcide announced its first corporate partnership in the form of a multi-year collaborative agreement with Ortho-McNeil Pharmaceuticals, a division of Johnson & Johnson, to develop therapeutic compounds for Gram-positive bacterial infections.

Full browser ?